Liver transplant kids test cutting meds in half

NCT ID NCT07549503

Recruiting now Disease control Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether children who received a liver transplant before age 7 can safely cut their anti-rejection drugs by 50%. One hundred kids will slowly reduce their medication over 18 months, with frequent blood tests and liver biopsies to check for rejection. The goal is to see if lower doses can keep the liver healthy while reducing side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER TRANSPLANT

Contacts and locations

Locations

Ann and Robert H. Lurie Children's Hospital of Chicago
RECRUITING

Chicago, Illinois, 60611, United States
Children's Hospital Colorado
NOT_YET_RECRUITING

Aurora, Colorado, 80045, United States
Children's Hospital of Philadelphia
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 15224, United States
Cincinnati Children's Hospital Medical Center
RECRUITING

Cincinnati, Ohio, 45229, United States
Columbia University Medical Center
NOT_YET_RECRUITING

New York, New York, 10032, United States
Emory University School of Medicine/Children's Healthcare of Atlanta
NOT_YET_RECRUITING

Atlanta, Georgia, 30307, United States
Icahn School of Medicine at Mount Sinai
NOT_YET_RECRUITING

New York, New York, 10029, United States
MedStar Georgetown University Hospital
NOT_YET_RECRUITING

Washington D.C., District of Columbia, 20007, United States
Monroe Carell Jr. Children's Hospital at Vanderbilt
NOT_YET_RECRUITING

Nashville, Tennessee, 37232, United States
UCSF Benioff Children's Hospital
NOT_YET_RECRUITING

San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.